Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study will be a randomized, blinded, placebo-controlled two-group clinical trial. The
independent variable is treatment assignment (active 4-mg nicotine lozenge vs. matching
placebo lozenge), and the dependent variables are all tobacco and ST abstinence at 3 and 6
months. ST users will be randomly assigned to either the 4-mg active nicotine lozenge or
matching placebo.